AG
BMY icon

Algert Global’s Bristol-Myers Squibb BMY Stock Holding History

Algert Global’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.33M Buy
161,894
+9,694
+6% +$557K 0.11% 290
2026
Q1 		$9.23M Sell
152,200
-5,919
-4% -$345K 0.14% 227
2025
Q4 		$8.53M Buy
158,119
+16,980
+12% +$817K 0.13% 261
2025
Q3 		$6.37M Buy
+141,139
New +$6.59M 0.11% 338
2025
Q2 		– Sell
-12,090
Closed -$737K – 1188
2025
Q1 		$737K Sell
12,090
-91,485
-88% -$5.33M 0.02% 830
2024
Q4 		$5.86M Buy
103,575
+4,219
+4% +$236K 0.14% 233
2024
Q3 		$5.14M Buy
99,356
+91,455
+1,158% +$4.29M 0.14% 245
2024
Q2 		$328K Buy
+7,901
New +$354K 0.01% 1090

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Algert Global's BMY Position: Q2 2026 in Review

Algert Global increased its Bristol-Myers Squibb (BMY) stake by 6.4% in Q2 2026, buying an estimated $557K and bringing the position to 161,894 shares worth $9.33M. The position accounts for 0.11% of the portfolio, ranked #290.

Algert Global first reported a position in BMY in Q2 2024 and has held it in 8 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Algert Global held 161,894 shares of Bristol-Myers Squibb worth $9.33M as of Q2 2026.
  • Algert Global bought 9,694 Bristol-Myers Squibb shares in Q2 2026, an estimated $557K.
  • Bristol-Myers Squibb made up 0.11% of Algert Global's portfolio in Q2 2026, its #290 holding.
  • Algert Global first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 8 quarters since.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.